Navigation Links
EMKinetics Announces Start of Pivotal Trial for the TranStim™ Transdermal Neuromodulation System
Date:10/14/2011

CAMPBELL, Calif., Oct. 14, 2011 /PRNewswire/ -- EMKinetics, Inc. announced today initiation of the TranStim™ Transdermal Neuromodulation System pivotal trial for patients suffering from urge incontinence and overactive bladder.  The 120-person trial will be conducted at 10-15 US centers.  Submission for CE mark and 510(k) clearance will follow the completion of the study.   EMKinetics' TranStim therapy builds on the body of evidence that posterior tibial nerve stimulation (PTNS) can generate a clinically significant improvement in patients suffering from urge incontinence and overactive bladder.  

"This appears to be the next evolutionary step for PTNS technology," said Marshall Stoller, MD, EMKinetics co-founder and professor and vice chair in the Department of Urology at the University of California, San Francisco. "We are confident that the TranStim System has the potential to safely and consistently provide transdermal PTNS therapy.  We believe this advancement will be well received by this desperate patient population and the physicians caring for them."  

The initiation of the pivotal trial follows the closing of EMKinetics' Series C financing of $8.0 million, led by a strategic investment from Allergan, Inc., a global multi-specialty healthcare company with a strong and growing urology portfolio.  Series B investor, Scientific Health Development, and four new institutional investors, Easton Capital, Oakwood Medical Investors, Legacy Life Sciences and Millennium Life Sciences Fund, filled out the round.

"Allergan, which is widely known for its specialty pharmaceuticals, has also become a significant participant in medical devices and is emerging as a leader in urologic therapies", said Daniel Burnett, MD, co-founder and director of EMKinetics. "Their financial support in an area they know so well is both gratifying and important to our company."

About EMKinetics, Inc.

The f
'/>"/>

SOURCE EMKinetics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 2014  The law firm McElroy, Deutsch, Mulvaney ... will serve as host for "Show Me the ... of Healthcare Reform," a one-day conference scheduled for ... reimbursement, compliance and enforcement in a marketplace re-shaped ... Logo -  http://photos.prnewswire.com/prnh/20140916/146606 Logo -  http://photos.prnewswire.com/prnh/20140916/146607 ...
(Date:9/17/2014)... ANGELES and LEIPZIG, Germany ... today announced that it has entered into an ... the development of antibody-based imaging agents to image ... "Our collaboration with Novotectid expands ImaginAb,s capability to precisely ... immune-oncology and autoimmune disease areas. The ability to ...
(Date:9/17/2014)...   GS1 US has published a ... to support the 2013 Drug Supply Chain Security ... in the pharmaceutical supply chain. The document, titled ... Supply Chain Business Processes to Support the Drug ... in collaboration with GS1 Healthcare US®, a GS1 ...
Breaking Medicine Technology:Three Leading Healthcare Organizations Sponsor Conference to Examine Opportunities and Risks of Healthcare Reform for Providers 2ImaginAb Expands ImmunoPET Pipeline to Include CD4+ T-Cell Imaging 2New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 2New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 3New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 4
... Results Further Validate Lipidomic-Based Therapeutics as an Emerging Area ... ... DIEGO, Sept. 4 Lpath, Inc. (OTC Bulletin,Board: LPTN), the ... in several murine models of human cancer,and AMD with Lpathomab(TM), ...
... HistoRx AQUA(R)-based assays to evaluate, clinical utility of protein ... ... -, NEW HAVEN, Conn., Sept. 4 HistoRx, Inc., ... the Radiation,Therapy Oncology Group (RTOG), a National Cancer Institute-funded clinical,cooperative ...
Cached Medicine Technology:Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process 2Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process 3HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership 2HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership 3
(Date:9/17/2014)... of wine leads to an explosion of flavours in your ... nanosensor that can mimic what happens in your mouth when ... sensation of dryness in the wine. , When wine growers ... number of processes to bring out the desired flavour in ... important part of the taste is known in wine terminology ...
(Date:9/17/2014)... Francisco, CA (PRWEB) September 17, 2014 ... at http://www.marijuanastock.net , recently launched a “Video” ... the different cannabis companies in the marijuana industry ... video section, a website visitor is given access ... videos relevant to marijuana-related businesses and the issues ...
(Date:9/17/2014)... FL (PRWEB) September 17, 2014 Fresh ... is pleased to announce its support of The Silver ... seniors understanding of the many benefits of medical marijuana. ... be the first medical marijuana dispensary and ... which is raising funds to launch a statewide radio ...
(Date:9/17/2014)... September 17, 2014 NetDimensions (AIM: NETD; ... learning management systems, announces the opening of the 2014 ... IL. , "We are very excited to meet up ... tremendous interest in Next Steps from our clients and ... community really is. We look forward to some very ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Altec Products, ... solutions, announced today their Gold Sponsorship of the 2014 ... 2014. The annual conference will take place in Dallas, ... – 23 and is organized and hosted by the ... non-profit organization comprised of members from more than 900 ...
Breaking Medicine News(10 mins):Health News:Nanoscience makes your wine better 2Health News:Nanoscience makes your wine better 3Health News:MarijuanaStock.net Adds Business News Video Section to Their Website 2Health News:Florida Buds Supports Silver Tour 2Health News:NetDimensions Next Steps User Conference in North America Opens Today with Record Attendance 2Health News:NetDimensions Next Steps User Conference in North America Opens Today with Record Attendance 3Health News:Altec Joins the 2014 Epicor Prophet 21 World Wide User Group Conference as a Gold Sponsor 2Health News:Altec Joins the 2014 Epicor Prophet 21 World Wide User Group Conference as a Gold Sponsor 3
... genetic disease that causes deafness and dumbness has hit a ... victims belong to Gujjar community. // ,Health and Medical ... that at least 72 cases of the disease have surfaced ... New born babies are also affected by the disease" ...
... the brain of mice were augmented, conditions similar to ... was reported by researchers from Stanford University Medical Centre ... in the treatment of this disease in humans. According ... a drug along with cannabis-like chemicals resulted in a ...
... genetic disease, genetics researchers have identified a novel biological ... development, potentially in cases of mental retardation and autism. ... two genes that contribute to Cornelia deLange syndrome (CdLS), ... in 10,000 children. The disease varies from milder to ...
... by x-ray crystallography. The bundle contains eight copies of ... like and unlike colors, respectively. ,Researchers ... found in natural proteins, discovering that they can form ... protein. Their findings could help scientists design drugs that ...
... According to one of the major findings of a ... less than children who sleep less, and they //are ... years later. The results of this new study were ... Child Development. ,Conducted by researchers at ...
... artemisinin-based combination therapies to prevent malaria //parasites from developing ... the National Agency for Food and Drug Administration and ... the parasite already has grown resistant to chloroquine and ... be difficult to find another malaria treatment. ...
Cached Medicine News:Health News:Gene Found for Rare Disorder May Reveal New Pathway in Mental Retardation 2Health News:Man-Made Proteins Could Be More Useful Than Real Ones 2Health News:Man-Made Proteins Could Be More Useful Than Real Ones 3Health News:Childhood Obesity Linked With Sleep 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: